In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine
about
Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada.Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methodsItraconazole (Sporanox) in superficial and systemic fungal infections.Malassezia yeasts in the pathogenesis of atopic dermatitis.Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosaProlonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patientUpdate on the genus Malassezia.Pityriasis versicolor: an update on pharmacological treatment options.Malassezia species in healthy skin and in dermatological conditions.Topical ear treatment - options, indications and limitations of current therapy.The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study.Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.A 34-Year-Old Man With Cough, Lung Nodules, Fever, and Eosinophilia.In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa.Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial.Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.Itraconazole corneofungimetry bioassay on Malassezia species.Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds.In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.Pityriasis versicolor: a case of resistance to treatment.Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences.Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis.An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu, China.Molecular analysis of Malassezia species isolated from hospitalized neonates.Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor.
P2860
Q30651586-75C27D70-722B-4BFA-9808-66350D88AEBEQ35072285-298539BA-C515-4C0E-9D7D-41C1FE43BA60Q35112507-C8148834-A99D-4EC3-9CC4-D49E2D72A6E8Q35917270-A00F4A2A-7D4A-4C0D-A5C8-53728713B48DQ35939774-2FAA5E29-3418-4044-B9F5-89244F46A6AFQ36049722-886DD8D6-79D2-4A9E-8D23-C6C8FD8652B3Q36277839-7864D6BB-DAA4-4E51-95B0-5D2CA74FB35AQ36825709-E4BBD16B-13CE-4602-B2D3-0454B9F6991EQ38225892-9040D1A8-5523-43D4-9C4A-6BC5F615E8AFQ38681469-D554ECDE-07A0-4FBA-9CC4-1266C884ACE9Q38982314-1BED8BEA-7B8F-44F1-BDE8-9D4F380A3D7CQ39256082-A5FAD816-2C4D-4829-9109-A2F44EE28566Q39357114-91E7A9DD-DD9C-44B9-9FA5-4A7700C33B70Q39393643-890E5B77-5CD0-414F-B9A4-5C71352EFD75Q40080276-E6A984FD-F8B8-4A2F-9551-4ECF3D9B648CQ40234516-44586E73-D28D-42D9-9560-81C9787D888AQ40440181-E1AF28FE-BC6D-4CCA-8AED-695CC35A3927Q40750682-0EAD4A45-B122-4336-8BA5-4D7C76CD8953Q43784531-76CB6728-1950-4462-8058-B6C385AEDFF5Q44468393-CC91CEB0-5213-4D5A-8FE7-0B54AC2F65F2Q44539867-0DF09CA6-0C0E-4EFF-8902-4B47D0106833Q44729371-7D74B2A6-F17C-4424-830B-311D0A22CDC3Q45374648-8DC797B1-725B-496E-84D8-7FCF61B03A4DQ46379011-73DC032F-B469-4331-9815-26B2E0BDDC0BQ47711304-7E863E17-4197-49BC-B056-8B0F64A85CAEQ54270009-CE55E35E-B82D-4916-A8E8-7E54EFBD3506Q54527328-93DD49B2-FB43-4C84-B9F6-574A54FD74CAQ55043230-BACBB5D2-202A-4651-8DA8-D49BF517D5F1
P2860
In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine
description
article
@en
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
In vitro susceptibility of the ...... , itraconazole and terbinafine
@en
In vitro susceptibility of the ...... , itraconazole and terbinafine
@nl
type
label
In vitro susceptibility of the ...... , itraconazole and terbinafine
@en
In vitro susceptibility of the ...... , itraconazole and terbinafine
@nl
prefLabel
In vitro susceptibility of the ...... , itraconazole and terbinafine
@en
In vitro susceptibility of the ...... , itraconazole and terbinafine
@nl
P2093
P2860
P1476
In vitro susceptibility of the ...... , itraconazole and terbinafine
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.2000.03294.X
P407
P577
2000-04-01T00:00:00Z